SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-255560
Filing Date
2022-09-30
Accepted
2022-09-30 16:31:08
Documents
14
Period of Report
2022-09-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d394349d8k.htm   iXBRL 8-K 26168
2 EX-99.1 d394349dex991.htm EX-99.1 15339
6 GRAPHIC g394349g0930093437170.jpg GRAPHIC 2622
  Complete submission text file 0001193125-22-255560.txt   175338

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20220930.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20220930_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20220930_pre.xml EX-101.PRE 11705
8 EXTRACTED XBRL INSTANCE DOCUMENT d394349d8k_htm.xml XML 3437
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 221284488
SIC: 2834 Pharmaceutical Preparations